Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients…
Cybin (NEO: CYBN) (NYSE American: CYBN), a biotechnology company focused on psychedelic pharmaceutical therapies, has noted key achievements reached by…
Mr. Greg McKee, CEO of Tryp Therapeutics, appeared on The Dealmaker Podcast to share insights on the company and the…
Mind Cure Health Inc. announced Jerry White’s appointment into the company’s advisory board Mr. White brings a wealth of experience…
SRAX will host 2021 LD Micro Main Event on October 12-14, 2021 Conference is set to be held in in-person…
Expect 1Q:21 Was A Trough Quarter; Project A 15% Sequential 2Q:21 Revenue Increase; LGL Group (NYSE American: LGL) was featured…
Maintain Projected Three-Year EBITDA CAGR Of About 44% PLBY Group (NASDAQ: PLBY) was featured in a company-sponsored research earnings preview…
InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates as well as manufacturing technologies for pharmaceutical-grade rare…
Total Revenue Up 120% Year-Over-Year Freedom Holding (NASDAQ: FRHC) was featured in a company-sponsored research earnings preview note published…
Strong Revenue Trends, Margin Expansion Information Services Group (NASDAQ: III) was featured in a company-sponsored research earnings release note published…